Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34 |
filingDate |
2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_644f31b38853f94f704cd059363ed842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f891207ac3cc5e95f278121f101669 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3efe957bdd143b4b3e62b8fbcca1eceb |
publicationDate |
2004-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1424324-A1 |
titleOfInvention |
Crystalline form F of Atorvastatin hemi-calcium salt |
abstract |
The present invention is directed to the novel polymorphic Form F of Atorvastatin calcium,nprocesses for the preparation therof and pharmaceutical compositions comprising thisncrystalline form. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2420488-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674923-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10252993-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006037125-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8080672-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100923939-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012031130-A |
priorityDate |
2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |